BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 18708696)

  • 1. Use of an electrochemically synthesised metabolite of a selective androgen receptor modulator for mass spectrometry-based sports drug testing.
    Thevis M; Lohmann W; Schrader Y; Kohler M; Bornatsch W; Karst U; Schänzer W
    Eur J Mass Spectrom (Chichester); 2008; 14(3):163-70. PubMed ID: 18708696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doping control analysis of tricyclic tetrahydroquinoline-derived selective androgen receptor modulators using liquid chromatography/electrospray ionization tandem mass spectrometry.
    Thevis M; Kohler M; Thomas A; Schlörer N; Schänzer W
    Rapid Commun Mass Spectrom; 2008 Aug; 22(16):2471-8. PubMed ID: 18634123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator S-22 to identify potential targets for routine doping controls.
    Thevis M; Thomas A; Möller I; Geyer H; Dalton JT; Schänzer W
    Rapid Commun Mass Spectrom; 2011 Aug; 25(15):2187-95. PubMed ID: 21710598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a non-approved selective androgen receptor modulator drug candidate sold via the Internet and identification of in vitro generated phase-I metabolites for human sports drug testing.
    Thevis M; Lagojda A; Kuehne D; Thomas A; Dib J; Hansson A; Hedeland M; Bondesson U; Wigger T; Karst U; Schänzer W
    Rapid Commun Mass Spectrom; 2015 Jun; 29(11):991-9. PubMed ID: 26044265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for two selective androgen receptor modulators using gas chromatography-mass spectrometry in doping control analysis.
    Thevis M; Kohler M; Schlörer N; Fusshöller G; Schänzer W
    Eur J Mass Spectrom (Chichester); 2008; 14(3):153-61. PubMed ID: 18708695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of selected in vitro generated phase-I metabolites of the steroidal selective androgen receptor modulator MK-0773 for doping control purposes.
    Lagojda A; Kuehne D; Krug O; Thomas A; Wigger T; Karst U; Schänzer W; Thevis M
    Eur J Mass Spectrom (Chichester); 2016; 22(2):49-59. PubMed ID: 27419898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of the arylpropionamide-derived selective androgen receptor modulator (SARM) S-4 (Andarine) in a black-market product.
    Thevis M; Geyer H; Kamber M; Schänzer W
    Drug Test Anal; 2009 Aug; 1(8):387-92. PubMed ID: 20355219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of equine urinary metabolites of selective androgen receptor modulators (SARMs) S1, S4 and S22 for doping control purposes.
    Hansson A; Knych H; Stanley S; Thevis M; Bondesson U; Hedeland M
    Drug Test Anal; 2015 Aug; 7(8):673-83. PubMed ID: 25560998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for metabolically stable aryl-propionamide-derived selective androgen receptor modulators for doping control purposes.
    Thevis M; Kamber M; Schänzer W
    Rapid Commun Mass Spectrom; 2006; 20(5):870-6. PubMed ID: 16470709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass spectrometry of selective androgen receptor modulators.
    Thevis M; Schänzer W
    J Mass Spectrom; 2008 Jul; 43(7):865-76. PubMed ID: 18521833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of in vitro generated metabolites of the selective androgen receptor modulators S-22 and S-23 and in vivo comparison to post-administration canine urine specimens.
    Thevis M; Gerace E; Thomas A; Beuck S; Geyer H; Schlörer N; Kearbey JD; Dalton JT; Schänzer W
    Drug Test Anal; 2010; 2(11-12):589-98. PubMed ID: 20967890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding sports drug testing assays: mass spectrometric characterization of the selective androgen receptor modulator drug candidates RAD140 and ACP-105.
    Thevis M; Piper T; Beuck S; Geyer H; Schänzer W
    Rapid Commun Mass Spectrom; 2013 Jun; 27(11):1173-82. PubMed ID: 23650030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro metabolism studies on the selective androgen receptor modulator (SARM) LG121071 and its implementation into human doping controls using liquid chromatography-mass spectrometry.
    Knoop A; Krug O; Vincenti M; Schänzer W; Thevis M
    Eur J Mass Spectrom (Chichester); 2015; 21(1):27-36. PubMed ID: 25906032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator andarine (S-4) for routine doping control purposes.
    Thevis M; Thomas A; Fusshöller G; Beuck S; Geyer H; Schänzer W
    Rapid Commun Mass Spectrom; 2010 Aug; 24(15):2245-54. PubMed ID: 20623476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid chromatography-high resolution/ high accuracy (tandem) mass spectrometry-based identification of in vivo generated metabolites of the selective androgen receptor modulator ACP-105 for doping control purposes.
    Thevis M; Thomas A; Piper T; Krug O; Delahaut P; Schänzer W
    Eur J Mass Spectrom (Chichester); 2014; 20(1):73-83. PubMed ID: 24881457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural elucidation of major selective androgen receptor modulator (SARM) metabolites for doping control.
    Garg N; Hansson A; Knych HK; Stanley SD; Thevis M; Bondesson U; Hedeland M; Globisch D
    Org Biomol Chem; 2018 Jan; 16(5):698-702. PubMed ID: 29319101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass spectrometry of hydantoin-derived selective androgen receptor modulators.
    Thevis M; Kohler M; Schlörer N; Kamber M; Kühn A; Linscheid MW; Schänzer W
    J Mass Spectrom; 2008 May; 43(5):639-50. PubMed ID: 18095383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for 2-quinolinone-derived selective androgen receptor agonists in doping control analysis.
    Thevis M; Kohler M; Maurer J; Schlörer N; Kamber M; Schänzer W
    Rapid Commun Mass Spectrom; 2007; 21(21):3477-86. PubMed ID: 17985352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARM-S4 and metabolites detection in sports drug testing: a case report.
    Grata E; Perrenoud L; Saugy M; Baume N
    Forensic Sci Int; 2011 Dec; 213(1-3):104-8. PubMed ID: 21816554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-depth metabolic study of nonsteroidal selective androgen receptor modulator GSK2881078 in thoroughbred horses and horse liver microsomes for doping control.
    Karatt TK; Sathiq MA; Laya S; Kal AKK; Subhahar MB; Muhammed Ajeebsanu MP; Philip M; Caveney MR; Graiban FM
    Drug Test Anal; 2023 Jul; 15(7):757-768. PubMed ID: 36922727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.